Continuing Education

Our webinars offer free NAADAC and PCB CEUs. Information about obtaining CEUs and webinar certificates can be found here.

Engaging Reluctant Participants in SUD Group Counseling: “Gimmicks for Group”

Wednesday, June 3 | 12pm – 1:30pm Eastern Time

Register Now

Wait! Before you register, please give us a case example (or two or three) to help guide the conversation on June 3. Dr Chapman will select certain cases to highlight, and yours might be chosen!


Although all practitioners develop their own style of running groups with clients with substance use disorders (SUDs), their individual approaches play an important role in determining the ultimate efficacy of this treatment modality. Specific group techniques, or as they will be called in this webinar, “gimmicks,” may help create an environment that is both energizing for practitioners as well as engaging for clients. This webinar is designed to involve attendees in a virtual consultation on disarming client reluctance to becoming involved in group counseling.

Several example gimmicks designed to engage resistant group members will serve to “prime the pump” for the discussion of specific situations suggested by attendees. These gimmicks will suggest means by which to facilitate the movement of individuals in a “pre-contemplative” or “contemplative” stage of readiness to change towards the “next” stage as suggested in Prochaska’s Transtheoretical Model of Change. Attendees will then be invited to submit specific scenarios for discussion with the presenter during the webinar.


Robert Chapman, PhD, is an experienced practitioner and educator who for 45+ years has worked in both in- and outpatient SUD treatment programs. Since 1988, his professional interests have focused on high-risk and dangerous collegiate drinking and other drug use. He is a retired Clinical Associate Professor of Behavioral Health Counseling and an adopted member of the Seneca Nation of Indians.

Cannabis Therapeutics & Policy: A Substantive Discussion of a Substance Worth Discussing

Thursday, June 11 | 3pm – 5pm Eastern Time

Register Now


In this webinar, you’ll learn about therapeutic and policy considerations in the medical use of cannabis from three expert instructors who have taught thousands of clinicians in state-approved certification courses. After a brief review of the endocannabinoid system and pharmacology, we’ll focus on considerations around practice integration, risk management and addiction. How do you discuss potential drug interactions, adverse events, and cannabis use disorder with patients? What protocols should be in place for your facility, program, or hospital? We’ll discuss regulatory concerns and controversies, including the impact of cannabis legalization on the drug overdose crisis, and leave plenty of time for your questions.


Christine Roussel, PharmD, BCOP is a Board-certified Oncology Pharmacist with a bachelor’s degree in Toxicology and a doctorate in Pharmacy from University of the Sciences in Philadelphia. Her passions include occupational exposure to hazardous drugs, compounding and legislative topics, such as medical cannabis. ?Dr Roussel is Director of Pharmacy at Doylestown Hospital, co-founder of the American Society of Cannabis Pharmacists, course director of a DOH-approved 4-hour medical cannabis course, and a popular lecturer nationally and regionally.

Adam C. Lake, MD, FAAFP, AAHIVS, FACMQ practices at Penn LGHealth in Lancaster, where he is on the faculty of the family medicine residency program. His areas of expertise include addiction medicine, HIV/AIDS, Hep-C, and lesbian, gay, bisexual, and transgender health. Dr Lake studied linguistics and biochemistry at Grinnell College, medicine at Temple University, permaculture & traditional medicine in Latin America, and completed a fellowship in population health. Dr Lake is a registered physician in the PA Medical Marijuana program, and lectures locally and regionally on treatment of opioid use disorder and medical marijuana.

Gail Groves Scott, MPH is a opioid use disorder policy researcher, doctoral student, and public health consultant. She researches access to treatment medications, as well as the impact of the pharmaceutical industry on medical education and policy. Gail launched the University of the Sciences’ Substance Use Disorders Institute in 2018-19, and managed their medical cannabis continuing education training approved by the Pennsylvania Department of Health to certify medical professionals. A whistleblower in a record-setting Department of Justice case, Gail was a pharma sales representative for more than 16 years prior to changing careers to work in public health policy.